devdiscourse1 天
Cipla's Strategic Investment in South Africa: Boosting Pharma Operations
Cipla Ltd is set to invest ZAR 900 million in its wholly-owned subsidiary, Cipla Medpro South Africa Proprietary Ltd. The ...
The Financial Express6 天
Motilal Oswal maintains Neutral on Cipla. 3 key worries are…
Motilal Oswal retains Neutral on Cipla; see limited upside due to delayed niche product approvals. Learn more about the ...
devdiscourse7 天
Cipla's Q3 Net Profit Surges by 48.73% on Global Growth
Cipla reported a 48.73% increase in consolidated net profit for Q3 2024. The growth was attributed to improved performance ...
Brokerages divided on Cipla despite strong Q3 earnings beat; buy or sell?
The shares of the third largest pharmaceutical firm Cipla rose 2.44 per cent at Rs 1,454.20 a piece on the BSE intraday after ...
Cipla Q3 Results: Pharmaceutical company's net profit rises 49% to Rs 1,575 crore, revenue ...
Results: Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net ...
Cipla Q3 result: Profit up 49% at Rs 1,571 cr on strong demand in N America
The company's consolidated net profit increased nearly 49 per cent to Rs 1,571 crore ($181.6 million) in the October-December ...
moneycontrol.com6 年
Cipla Medpro
Cipla Medpro, South Africa's third-largest pharmaceutical company in the private sector, will also pay certain milestone payment for the stake acquisition over a period of three years, subject to ...